229 related articles for article (PubMed ID: 28340873)
21. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.
de Leval L; Gisselbrecht C; Gaulard P
Br J Haematol; 2010 Mar; 148(5):673-89. PubMed ID: 19961485
[TBL] [Abstract][Full Text] [Related]
22. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
Rodriguez-Abreu D; Filho VB; Zucca E
Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
[TBL] [Abstract][Full Text] [Related]
23. Current treatment of peripheral T-cell lymphoma.
Horwitz SM; Coiffier B; Hsi ED; Pro B
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
[TBL] [Abstract][Full Text] [Related]
24. Durable Response in Relapsed Adolescent Peripheral T-cell Lymphoma: A Case Report and Review of the Literature.
Wedekind MF; Saraf A; Willen F; Audino AN
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e278-e281. PubMed ID: 33769385
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray.
Lunning MA
Oncology (Williston Park); 2015 Aug; 29(8):545-50. PubMed ID: 26281838
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
[TBL] [Abstract][Full Text] [Related]
29. A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.
Torimoto Y; Sato K; Ikuta K; Hayashi T; Hirayama Y; Inamura J; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Mori A; Ota S; Sakai H; Shigematsu A; Shindo M; Shinzaki H; Takahashi F; Takimoto R; Tanaka J; Yamamoto S; Kohgo Y; Fukuhara T
Int J Hematol; 2013 Aug; 98(2):171-8. PubMed ID: 23813410
[TBL] [Abstract][Full Text] [Related]
30. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
31. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
[TBL] [Abstract][Full Text] [Related]
32. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Amador C; Greiner TC; Heavican TB; Smith LM; Galvis KT; Lone W; Bouska A; D'Amore F; Pedersen MB; Pileri S; Agostinelli C; Feldman AL; Rosenwald A; Ott G; Mottok A; Savage KJ; de Leval L; Gaulard P; Lim ST; Ong CK; Ondrejka SL; Song J; Campo E; Jaffe ES; Staudt LM; Rimsza LM; Vose J; Weisenburger DD; Chan WC; Iqbal J
Blood; 2019 Dec; 134(24):2159-2170. PubMed ID: 31562134
[TBL] [Abstract][Full Text] [Related]
33. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
[TBL] [Abstract][Full Text] [Related]
34. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Timmins MA; Wagner SD; Ahearne MJ
Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified.
Lin Y; Chen WM; Wang C; Chen XY
Cancer Biomark; 2017; 18(4):339-347. PubMed ID: 28128734
[TBL] [Abstract][Full Text] [Related]
36. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
[TBL] [Abstract][Full Text] [Related]
37. Therapies for peripheral T-cell lymphomas.
Savage KJ
Hematology Am Soc Hematol Educ Program; 2011; 2011():515-24. PubMed ID: 22160083
[TBL] [Abstract][Full Text] [Related]
38. [T-bet in peripheral T-cell lymphoma].
Wang Z; Zhang DB; Zhou W
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):779-783. PubMed ID: 27719721
[TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.
Mehta N; Maragulia JC; Moskowitz A; Hamlin PA; Lunning MA; Moskowitz CH; Zelenetz A; Matasar MJ; Sauter C; Goldberg J; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):664-70. PubMed ID: 24035712
[TBL] [Abstract][Full Text] [Related]
40. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
Li M; Lü N; Liu HX; Chen DB; Zhang JZ
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]